Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest. Moss P, Berenbaum F, Curigliano G, Grupper A, et al. Vaccine 2022 May 27. pii: S0264-410X(22)00682.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Moss P, Berenbaum F, Curigliano G, Grupper A, et al. Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest. Vaccine 2022 May 27. pii: S0264-410X(22)00682.
PMID: 35718592